Carrier Screening Market Size to Reach USD 6.13 Billion in 2027 | Emergen Research

Increasing prevalence of genetic disorders worldwide, rising adoption of next-generation sequencing technology in carrier screening, and growing awareness about early diagnosis and detection are some key factors expected to drive global Carrier Screening market growth.

According to Emergen Research, the global carrier screening market size was USD 1.70 billion in 2019 and is expected to reach USD 6.13 billion in 2027 and register a robust revenue CAGR of 17.4% during the forecast period, 2020-2027.

Market Dynamics:

Carrier screening is a type of genetic testing used for determining if an individual is a carrier of specific autosomal recessive diseases. These tests are usually performed by individuals who are planning on becoming pregnant in order to evaluate the chances of their child inheriting one of the genetic diseases. Factors such as growing demand for customized medicines, increasing applications of carrier screening in testing genetic disorders, and rising investments in development of novel systems and tests are expected to drive global market revenue growth during the forecast period. 

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @

However, factors such as lack of well-developed infrastructure due to insufficient funds, dearth of skilled healthcare professionals, and low awareness about importance of screening in many developing and underdeveloped economies are expected to hamper overall market growth to a certain extent during the forecast period.

COVID-19 Impact Analysis 

  • Social distancing and restrictions severely disrupted businesses and operations
  • Lockdowns caused disruptions in transportation and logistics
  • Impacted manufacturing activities and mining operations globally
  • Took a toll on economy of various countries
  • Caused sudden and drastic downturn in economic activity
  • Disrupted agriculture, fisheries, dairy, and other sectors
  • Caused loss of employment and financial crisis
  • Supply impacts were further compounded owing to reduced disposable income
  • Emergence of variants continue to cause concerns and impact normal routines

DNA Sequencing Segment To Register Significant Revenue CAGR:

The DNA sequencing segment is expected to register significant revenue CAGR over the forecast period. This can be attributed to rapid advancements in sequencing technology, high preference for DNA sequencing for more accurate results, and increasing awareness about early diagnosis. 

Browse Full Report Description + Research Methodology + Table of Content + Infographics@

Hospital Segment to Account for Largest Revenue Share:

The hospital segment is expected to account for largest revenue share between 2020 and 2027 owing to increasing patient pool, rising hospital admissions, and growing adoption of advanced technologies, and advanced diagnostic tests.  

North America to Lead In Terms of Revenue Share:

North America is expected to account for largest revenue share in the global market during the forecast period owing to rising prevalence of genetic disorders, growing awareness about importance of carrier screening, rapid adoption of advanced technologies, and presence of well-developed healthcare facilities and infrastructure. 

Major Companies in the Market Include:

  • MedGenome Inc.
  • Luminex Corporation
  • Illumina Inc.
  • Otogenetics Corporation
  • Myriad Genetics Inc.
  • Thermo Fisher Scientific Inc.
  • Natera Inc.
  • Gene By Gene Ltd.
  • Corporation of America Holdings
  • Mount Sinai Genomics Inc.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @

For the purpose of this report, Emergen Research has segmented the global carrier screening market on the technology, medical condition, end-user, and region:

Technology Outlook (Revenue, USD Billion; 2017-2027)

  • DNA Sequencing
  • Polymerase Chain Reaction
  • Microarrays
  • Others

Medical Condition Outlook (Revenue, USD Billion; 2017-2027)

  • Pulmonary Conditions
  • Hematological Conditions
  • Neurological Conditions
  • Others

End-User Outlook (Revenue, USD Billion; 2017-2027)

  • Hospitals
  • Reference Laboratories
  • Physician Offices and Clinics
  • Others

Custom Requirements can be requested for this Report [Customization Available] @

Regional Outlook (Revenue, USD Billion; 2017–2027)

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • U.A.E.
    • South Africa
    • Turkey
    • Rest of MEA

Read Latest Blog Articles Published by Emergen Research:

Increasing Focus on Developing Viable Alternative and Sustainable Fuels to Drive Biofuels Market Growth

Top 10 Companies Shaping The Future Of Autonomous Vehicles Market

Top 9 Companies in the Animal Genetics Market Focusing on Improving Health of Economically Important Animals

World’s Top 9 Leading Companies in the Automotive Aftermarket

Top 10 Companies Offering Next-Gen Battery Technologies That Will Power the Future

Top 10 Gaming Mouse Brands To Choose From For Ardent Gamers

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend’s existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web:

Direct Line: +1 (604) 757-9756


Emergen Research Media Citations:

Visit for More Insights:

Explore Our Custom Intelligence services | Growth Consulting Services

Press Release Available @

Read Blog @

Back to news